Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke

Stem Cells Translational Medicine

Volumn 3, Issue 11, 2014, Pages 1322-1331

  Banerjee, Soma ^a   Bentley, Paul ^a   Hamady, Mohammad ^a   Marley, Stephen ^a   Davis, John ^a   Shlebak, Abdul ^a   Nicholls, Joanna ^b   williamson, Deborah A ^b   Jensen, Steen L ^b   Gordon, Myrtle ^c   Habib, Nagy ^b   Chataway, Jeremy ^a,d,e  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD34+; Intra arterial; Ischemic stroke; Stem cells

Indexed keywords

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; BONE MARROW BIOPSY; BRAIN INFARCTION; BRAIN ISCHEMIA; CD34 SELECTION; CELL VIABILITY; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; INFUSION; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PROSPECTIVE STUDY; SAFETY; TRANSPLANTATION TOLERANCE; ACUTE DISEASE; AUTOGRAFT; BRAIN ANGIOGRAPHY; CLINICAL TRIAL; FOLLOW UP; INTRAARTERIAL DRUG ADMINISTRATION; RADIOGRAPHY; STEM CELL TRANSPLANTATION; STROKE;

CD34 ANTIGEN;

ACUTE DISEASE; AGED; ANTIGENS, CD34; AUTOGRAFTS; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; STROKE;

EID: 84908377598     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0178     Document Type: Article

References (32)

1. Chu K, Kim M, Jeong SW, et al. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003;343:129-133.
2. Chu K, Kim M, Park KI, et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 2004;1016:145-153.
3. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004;101: 11839-11844.
4. Borlongan CV, Tajima Y, Trojanowski JQ, et al. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 1998;149:310-321.
5. Stroemer P, Patel S, Hope A, et al. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair 2009;23:895-909.
6. Smith EJ, Stroemer RP, Gorenkova N, et al. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. STEM CELLS 2012;30:785-796.
7. Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005-1011.
8. Li Y, Chen J, Wang L, et al. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001;56: 1666-1672.
9. Li Y, Chopp M, Chen J, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000;20:1311-1319.
10. Shen LH, Li Y, Chen J, etal. Therapeuticbenefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood FlowMetab 2007;27:6-13.
11. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 2002;59:514-523.
12. Shyu WC, Lin SZ, Chiang M F, et al. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 2006;26:3444-3453.
13. Taguchi A, Soma T, Tanaka H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004;114:330-338.
14. Paczkowska E, Larysz B, Rzeuski R, et al. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Eur J Haematol 2005;75:461-467.
15. Dunac A, Frelin C, Popolo-Blondeau M, et al. Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol 2007; 254:327-332.
16. Moniche F, Gonzalez A, Gonzalez-Marcos JR, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke:Apilot clinical trial. Stroke 2012;43:2242-2244.
17. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary firstpass effect. Stem Cells Dev 2009;18:683-692.
18. Lappalainen RS, Narkilahti S, Huhtala T, et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett 2008;440:246-250.
19. McColgan P, Sharma P, Bentley P. Stem cell tracking in human trials: A meta-regression. Stem Cell Rev 2011;7:1031-1040.
20. Battistella V, de Freitas GR, da Fonseca LM, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 2011;6:45-52.
21. Suárez-Monteagudo C, Hernández-Ramírez P, Alvarez-González L, et al. Autologous bone marrow stem cell neurotransplantation in stroke patients: An open study. Restor Neurol Neurosci 2009;27:151-161.
22. Savitz SI, Misra V, Kasam M, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 2011;70: 59-69.
23. Friedrich MA, Martins MP, Araújo MD, et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant 2012;21 (suppl 1):S13-S21.
24. Shyu WC, Lin SZ, Yang HI, et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004;110:1847-1854.
25. Schäbitz WR, Kollmar R, Schwaninger M, et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-751.
26. England TJ, Abaei M, Auer DP, et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: The stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 2012;43:405-411.
27. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
28. IST-3 Collaborative Group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial. Lancet 2012;379:2352-2363.
29. Kondziolka D, Wechsler L, Goldstein S, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000;55:565-569.
30. Kondziolka D, Steinberg GK, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke:A phase 2 randomized trial. J Neurosurg 2005;103:38-45.
31. Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57: 874-882.
32. Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serumexpanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-1807.